Gesund.ai orchestrates the AI as-a-Medical Device lifecycle, providing privacy-centered access to diverse
yet standardized medical data sources, and a unique analytical toolbox that fosters clinical validation, regulatory clearance and effective marketing.
yet standardized medical data sources, and a unique analytical toolbox that fosters clinical validation, regulatory clearance and effective marketing.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Founded date: 2021
Investors 2
| Date | Name | Website |
| - | 500 Istanb... | istanbul.5... |
| - | Merck Digi... | mds.studio |
Mentions in press and media 6
| Date | Title | Description |
| 24.10.2024 | The Future of Healthcare AI: Standardization and Innovation | In the ever-evolving landscape of healthcare, artificial intelligence (AI) is a double-edged sword. It promises groundbreaking advancements but also poses significant challenges. The recent developments from Gesund.ai highlight a crucial st... |
| 21.10.2024 | HLTH: Gesund.ai’s Open-Source Library Aims to Standardize AI Validation in Healthcare | What You Should Know: – Gesund.ai, the clinical AI validation company, today announced the open sourcing of a comprehensive library of evaluation methodologies and frameworks to help developers and users address AI performance and potential... |
| 14.03.2024 | Gesund Expands AI Assurance Platform with Trillium Health Partners | Gesund’s AI Assurance Platform and experts are integrating THP’s high-quality data to provide a unique opportunity for rapid pressure-testing of AI models Gesund, the company ensuring that medical artificial intelligence (AI) is safe, equit... |
| 21.12.2022 | Merck Invests in Gesund, Launches Medical AI Platform on AWS | What You Should Know: While AI holds tremendous promise for the healthcare industry, the sector has unique challenges with respect to data training, testing and validation that directly impact the ability to ensure equity and effectiveness ... |
| 19.12.2022 | Merck Digital Sciences Studio Announces the Launch of its First Cohort | NEWARK, N.J. (PRWEB) December 19, 2022 On Friday December 16, Merck (NYSE: MRK) today announced the launch of their first biopharmaceutical cohort through the Merck Digital Sciences Studio (MDSS), a collaboration between Merck, Microsoft fo... |
| 28.02.2022 | Operations AI startup Qventus scores $50M and more digital health fundings | Photo: Gary Burchell/Getty Images |